InsurTech Funding Hit A Four-Year High, And 99.1% Of It Went To AI Companies

Global insurtech funding reached $2.44 billion in the second quarter of 2026, the highest quarterly total since the second quarter of 2022.

Of that, $2.42 billion went to AI-focused companies, or 99.1 per cent. Every deal above $5 million in the quarter went to an AI-focused business.

The concentration is not new. In the first quarter, AI-focused companies took 95.2 per cent of $1.63 billion, raising $1.55 billion across 68 deals at an average of $25.79 million. First-quarter funding was up 27 per cent year on year.

Underneath the headline the picture is narrower. Early-stage funding fell to roughly $264 million from $548 million in the previous quarter, less than half.

The nature of what is being funded has also shifted. Corgi Insurance raised $108 million alongside regulatory authority to operate as an AI-native, full-stack carrier serving startup companies, rather than as a technology supplier to existing insurers. Pace raised $46 million in a Series B for AI insurance operations.

Deployment data points the same way. A 2025 industry survey found generative AI adoption among insurers close to doubling year on year, with 55 per cent reporting early or full deployment and 90 per cent somewhere between pilot and production. Machine learning and predictive analytics sat at 74 per cent adoption.

Not all of the industry is convinced. A poll of 113 insurance industry respondents conducted across the first two quarters of 2026 found close to a quarter believed AI was not yet ready for widespread use in insurance, with liability for AI errors among the stated concerns.

Ninety-nine point one per cent is not a preference. It is a filter.

A funding market where every cheque above $5 million goes to a single category is not weighing AI against the alternatives. It has stopped considering them. An insurtech raising a growth round in 2026 without an AI thesis did not raise a smaller round. It did not raise.

The early-stage figure is where that becomes a problem. Seed and early funding halved quarter on quarter, to about $264 million. The recovery sits entirely in later, larger cheques written into companies that already exist. The layer that produces the next cohort is contracting while the top of the market expands.

That is a pipeline shrinking behind a headline that reads as health.

The composition change matters as much. Corgi did not raise $108 million to sell software to insurers. It raised it, with regulatory authority attached, to be an insurer. That is a different proposition, and it changes the customer relationship for everyone else in the sector. An incumbent carrier evaluating an AI vendor now has to weigh whether that vendor's logical next step is acquiring a licence and competing.

Concentration at a cycle high also carries history. The last quarter of comparable size was the second of 2022, and what followed it was two lean years.

For Indian insurtech the composition of this money is the uncomfortable part.

India's insurtech cohort is overwhelmingly built on distribution. Policybazaar aggregates and compares. Turtlemint connects customers to advisers. Coverfox brokes. Plum, Onsurity and Loop sell group health benefits to employers. These are good businesses and several are large. Almost none of them are underwriting or claims-decision companies.

Global capital is funding the opposite end. AI-native carriers, claims automation, underwriting models. The cheques are going to companies that price risk and settle claims, not to companies that find customers.

Domestic regulation is pressing on the same seam from the other side. IRDAI has opened consultation on a public insurance registry, a consent-driven record covering the full policy lifecycle, with feedback closing on 30 September. Its stated purpose is to reduce friction between market participants. Its effect is to erode the information advantage on which distribution businesses are built, and Bima Sugam does something comparable at the transaction layer.

So the Indian cohort faces pressure from two directions at once. The capital is funding a model they are not in, and the regulator is dismantling the moat around the model they are in.

A path across exists. Vitraya Technologies in Mohali automates claims adjudication rather than selling policies, which is the profile the money is going to. And IRDAI has continued granting licences, most recently approving Allianz Jio Reinsurance and Kiwi General Insurance, so becoming a carrier is not closed off.

What is missing is capital willing to fund the crossing. Indian venture took 1 per cent of global funding value in the first seven months of the year, and the domestic rounds that do close remain weighted towards distribution and benefits platforms.

An Indian AI-native carrier is a plausible business. Whether it is a fundable one here is a different sentence entirely.

For daily, sharp analysis of the biggest moves in the Indian business and startup ecosystem, follow StartupFox.